Additional file 2: of Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
收藏数据链接：
官方服务：
资源简介：
Figure S1. APRI and FIB-4 values at different time points in patients without SVR12 (n = 7). APRI (a). FIB-4 (b). APRI, AST/platelet ratio index; SVR12, sustained virologic response at 12 weeks after therapy; BA, baseline; 2W, week 2; 4W, week 4; EOT, end of therapy; PW12, 12 weeks after direct-acting antiviral therapy. All comparisons are made with baseline levels. *P < 0.05. (ZIP 83 kb)
提供机构：
figshare创建时间：
2019-04-28
